Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters (Q39881872)

15 September 2017

Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters (English)

1 reference

15 September 2017

1 reference

S Bortolanza

1

1 reference

15 September 2017

M Bunuales

2

1 reference

15 September 2017

P Alzuguren

3

1 reference

15 September 2017

O Lamas

4

1 reference

15 September 2017

R Aldabe

5

1 reference

15 September 2017

J Prieto

6

1 reference

15 September 2017

R Hernandez-Alcoceba

7

1 reference

15 September 2017

20 February 2009

1 reference

15 September 2017

1 reference

15 September 2017

16

1 reference

15 September 2017

9

1 reference

15 September 2017

703-712

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2009.12

15 September 2017

0 references

cites work

Oncolytic viral therapies - the clinical experience

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

Function of adenovirus E3 proteins and their interactions with immunoregulatory cell proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

Linked tumor-selective virus replication and transgene expression from E3-containing oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

"E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the ADP region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

Mutations within the ADP (E3-11.6K) protein alter processing and localization of ADP and the kinetics of cell lysis of adenovirus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

7 January 2021

The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

7 January 2021

Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

7 January 2021

A new hamster model for adenoviral vaccination

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

7 January 2021

Characterization of a single dose methylprednisolone acetate immune suppression model using Cryptosporidium muris and Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.12

7 January 2021

Identifiers

DOI

10.1038/CGT.2009.12

1 reference

Dimensions Publication ID

15 September 2017

0 references

1 reference